skip to primary navigationskip to content


Your drug discovery partner

At Stemnovate, we are developing stem cell based somatic cell models ‘on a chip’ to address current drug attrition rates. As a starting point we are developing liver based models. The major metabolic cell type found within the liver, the hepatocyte, plays a central role in human drug metabolism, and thus is of major importance to the safe drug development. We believe that by personalising cell based model development, and not assuming ‘one size fits all’, will result in safer and cheaper drug development. Our technology can be applied at various stages of the R&D process, including; profiling, hit-to-lead, lead optimisation and preclinical clinical R&D.

In addition to drug safety, we are studying more general aspects of human biology ‘in a dish’. Our unique access to well phenotyped tissue means that a range assays can be custom made to requirement.

Company Information

Year Founded: 2016

Number of Employees: 1-4

Company Website:


LinkedIn: Stemnovate